MedPath

Pregabalin augmentation in treatment resistant obsessive compulsive disorder:a randomized double blind controlled clinical trial

Phase 3
Conditions
Obsessive compulsive disorder.
Obsessive-compulsive disorder
Registration Number
IRCT20181225042113N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patient with impression of OCD according to DSM-V
Yale brown scale>15
Without any other psychiatric problem except OCD
Patient without medical problem
Do not use any substance

Exclusion Criteria

Pregnancy
Lactation
During psychotherapy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of yale brown scal. Timepoint: Before give pregabalin and after 12 week done yale brown scale. Method of measurement: Yale brown scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath